- The Wall Street Journal•10 hours ago
Facing mounting criticism about prices, drug companies put some limits on their increases this year.
- Associated Press•17 hours ago
As drugmakers pushed back against rising criticism over sky-high U.S. prescription drug prices, one pharmaceutical company went public with a pledge.
- Forbes•3 days ago
Todd Hagopian recently identified five sub-sectors of Biotech poised for the best potential returns under President Trump. Today Todd gives us a deep dive into NASH (Nonalcoholic Steatohepatitis), the sub-sector that he is most excited about for 2017.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||243.95 - 246.88|
|52 Week Range||184.50 - 299.11|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.43|
|Dividend & Yield||2.80 (1.14%)|
|1y Target Est||N/A|